Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
30.06. | Catheter Precision, Inc. Forms new Joint Venture Called Kardionav to Exploit patented AI Techniques to Create New VT Software platform | 114 | GlobeNewswire (Europe) | FORT MILL, S.C., June 30, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
26.06. | Catheter Precision, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
12.06. | Catheter Precision, Inc. Comments on Recent Market Activity | 96 | GlobeNewswire (Europe) | FORT MILL, S.C., June 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, is issuing... ► Artikel lesen | |
12.06. | Catheter Precision, Inc.: Catheter Precision (VTAK) Reports Key Progress for the LockeT Product | 4 | GlobeNewswire (USA) | ||
09.06. | Catheter Precision, Inc. Secures VIVO Purchase Order From Sahlgrenska University Hospital | 1 | GlobeNewswire (USA) | ||
CATHETER PRECISION Aktie jetzt für 0€ handeln | |||||
09.06. | Catheter Precision gibt Aktienoptionsschein an Ladenburg Thalmann aus | 2 | Investing.com Deutsch | ||
06.06. | Catheter Precision, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
30.05. | Catheter Precision, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
27.05. | Catheter Precision Inc.: Catheter Precision, Inc. Receives CE Mark for LockeT | 1 | GlobeNewswire (USA) | ||
19.05. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
14.05. | Catheter Precision reports Q1 results | 3 | Seeking Alpha | ||
14.05. | Catheter Precision, Inc. Announces First Quarter 2025 Update and Financial Results | 1.105 | GlobeNewswire (Europe) | FORT MILL, S.C., May 14, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced... ► Artikel lesen | |
13.05. | Catheter Precision raises $1.5M via private placement | 2 | Seeking Alpha | ||
13.05. | Catheter Precision, Inc. Announces $1.5 Million Private Placement Equity Financing and Potential Strategic Alliance | 5 | GlobeNewswire (USA) | ||
08.05. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
23.04. | Catheter Precision to acquire late-stage heart failure treatment assets in development | 1 | Seeking Alpha | ||
17.04. | Catheter Precision, Inc.: Catheter Precision Makes NYSE American Section 610(b) Public Announcement | 1 | GlobeNewswire (USA) | ||
16.04. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
01.04. | Catheter Precision, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
28.03. | Catheter Precision, Inc. Announces Fourth Quarter and Full Year 2024 Update and Financial Results | 306 | GlobeNewswire (Europe) | FORT MILL, S.C., March 28, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 41,410 | -1,36 % | Schock-News für Fresenius Anleger vor dem Wochenende: So müssen Sie heute noch auf diese Sondermeldung reagieren! | ||
FRESENIUS MEDICAL CARE | 46,320 | -0,37 % | EQS-PVR: Fresenius Medical Care AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius Medical Care AG
Fresenius Medical Care AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
10.07.2025... ► Artikel lesen | |
ECKERT & ZIEGLER | 67,30 | +1,13 % | EQS-News: Eckert & Ziegler SE: Ausbildungsqualität erneut ausgezeichnet | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Sonstiges
Eckert & Ziegler: Ausbildungsqualität erneut ausgezeichnet
15.07.2025 / 14:00 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
BICO GROUP | 3,100 | -0,06 % | Schock-News für Bico Group Anleger vor dem Wochenende: So müssen Sie heute noch auf diese Sondermeldung reagieren! | ||
SERNOVA BIOTHERAPEUTICS | 0,100 | +0,51 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
CARDINAL HEALTH | 138,40 | -0,25 % | Cardinal Health Launches One Voice Initiative To Empower Pharmacy Advocacy | WASHINGTON (dpa-AFX) - Cardinal Health (CAH) has introduced the Cardinal Health One Voice Initiative, a new program designed to financially support state pharmacy associations in bolstering... ► Artikel lesen | |
RESMED | 217,20 | -0,05 % | ResMed-Aktie mit leichten Kursgewinnen (221,8021 €) | Im US-amerikanischen Wertpapierhandel notiert der Anteilsschein von ResMed aktuell ein wenig fester. Der jüngste Kurs betrug 259,26 US-Dollar. Ein Wertzuwachs in Höhe von 3,28 US-Dollar erfreut derzeit... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,800 | +1,39 % | Atossa Therapeutics, Inc.: Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines... ► Artikel lesen | |
UNIDOC HEALTH | 0,150 | +2,46 % | UniDoc Health Corp. kündigt Teilnahme an der Ukraine Recovery Conference (URC2025) an | - UniDoc wird auf der internationalen Veranstaltung in Rom (Italien) seine laufenden humanitären und innovativen Bemühungen im Gesundheitswesen
präsentieren
VANCOUVER,... ► Artikel lesen | |
ZIMMER BIOMET | 80,98 | -0,02 % | Zimmer Biomet kauft Robotik-Spezialisten Monogram für 177 Millionen Dollar | Der Medizintechnik-Konzern Zimmer Biomet stärkt sein Geschäft mit orthopädischer Robotik: Das Unternehmen übernimmt Monogram Technologies für rund 177 Millionen US-Dollar. Wie beide Firmen am Montag... ► Artikel lesen | |
SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results | Revenues increased 9% in Q4 2025 compared to Q4 2024, and 12% in FY 2025 compared to FY 2024Net loss improved 27% in Q4 2025 compared to Q4 2024, and 29% in FY 2025 compared to FY 2024EBITDA loss improved... ► Artikel lesen | |
CO-DIAGNOSTICS | 0,228 | -2,56 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
CYTOSORBENTS | 0,900 | +1,81 % | Cytosorbents Corp: CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR | PRINCETON, N.J., July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions... ► Artikel lesen | |
VERU | 0,501 | 0,00 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China | Builds on clearances already received by FDA and EMAChina has the largest population of patients with hepatocellular carcinoma in the world BRISBANE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Tempest... ► Artikel lesen |